Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
DSFIR NA​

DSM-Firmenich AG/ADR(DSFIR NA)

$108.90+0.100.09%(Market Closed · 15:36:15 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingEmployees

DSM-Firmenich AG/ADR — Company Profile

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Sector
Industrials
Industry
Professional Services
Exchange
NA
CEO
Dimitri de Vreeze
Headquarters
Kaiseraugst, NY, CH
IPO Date
May 9, 2023
Employees
28,550
Website
www.dsm-firmenich.com

Key Metrics

Price
$97.38
Market Cap
$24.04B
Revenue (TTM)
$9.03B
Net Income (TTM)
$-1081000000.00
EPS (TTM)
-4.17
P/E (TTM)
33.48
P/B (TTM)
1.32
Dividend Yield
3.86%
ROE (TTM)
-5.93%
ROA (TTM)
-3.68%
Operating Margin
7.87%
Beta
0.22

Dividends

Last Dividend
$2.50
Last Yield
0.04%

Summary

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Website
www.dsm-firmenich.com
Location
Kaiseraugst, NY, CH
Phone41 61 815 17 26
Employees28,550
CEODimitri de Vreeze
Sector
Industrials
Industry
Professional Services
IPO DateMay 9, 2023

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(2)

Expand
  • EFFECTNotice of effectiveness21 Dec 2023
  • F-6Registration statement (depository shares)14 Dec 2023

Mentions in Filings

  • … nies are seeking to develop alternatives or supplements to conventional cacao cultivation in response to concerns relating to climate impact, supply volatility, and ethical sourcing. More broadly, competitors in our plant-based Foodtech markets include companies focused on plant cell culture for specialty ingredients, as well as established producers of plant-derived compounds and flavors, including <strong>DSM-Firmenich AG</strong> and Givaudan International SA.
    Pluri Inc.DSM-Firmenich AG/ADR·10-K - ANNUAL REPORT FY 2026·FY26·10 Sep
  • #\*DocMorris AG 35,396 257,409 dormakaba Holding AG 21,052 1,588,366 <strong>DSM-Firmenich</strong> AG 17,858 1,406,409 \*EFG International AG 81,839 2,091,542 Emmi AG, Registered 1,042 1,058,170 EMS-Chemie Holding AG 2,132 1,663,960
    Dimensional ETF TrustDSM-Firmenich AG/ADR·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … . 39 --- The market for supplying enzymes is fragmented. There is competition from large industrial enzyme companies, such as Novozymes and DuPont, as well as subsidiaries of larger contract research/CMOs, such as <strong>DSM-Firmenich AG</strong>, Cambrex Corporation, Lonza Group, WuXi STA and Almac Group Ltd. Some fermentation pathway design companies, like Ginkgo Bioworks, whose traditional focus has been to design microorganisms that express small molecule …
    CODEXIS, INC.DSM-Firmenich AG/ADR·10-Q - Quarterly report Q2·Q2 26·11 Aug
  • … During his tenure, he advised multi-national companies, financial institutions and family-controlled businesses on major transactions and corporate situations. Client experience included advising Burberry Group plc, <strong>DSM-Firmenich AG</strong>, First Eastern Investment Group, Kering SA, Melco Resorts & Entertainment Limited, INDITEX (Industria de Diseño Textil, S.A), New World Development Company Limited, Pacific Century Group and Prudential plc. Mr. Lo re …
    AParadise II Acquisition Corp.DSM-Firmenich AG/ADR·S-1 - REGISTRATION STATEMENT·Q2 26·8 Jun
  • 8 Sector Relevant Global Peer Group (incl. market cap) Peer group at median of market cap reflecting size, sector and geographical balance US CHEMICALS US SPECIALTY CHEMICALS COMPETITORS Paints & Coatings Sherwin - Williams €71.0bn PPG Industries €19.4bn RPM International €11.9bn EUROPEAN CHEMICALS BASF €38.7bn Givaudan €33.0bn DSM - Firmenich €18.1bn LyondellBasell €12.5bn Syensqo €7.1bn Evonik €6.5bn Arkema €3.9bn DuPont €19.3bn Dow Inc. €14.5b …
    Axalta Coating Systems Ltd.DSM-Firmenich AG/ADR·425 - Business combination communication·Q2 26·15 May
  • … ny Germany 38,731 65,260 109,717 Givaudan SA\* Switzerland Switzerland 32,950 7,976 17,580 DuPont United States United States 19,481 11,452 24,000 PPG Industries, Inc. United States United States 19,408 14,069 43,500 <strong>DSM-Firmenich AG</strong> Netherlands Switzerland 18,075 9,034 26,873 NewCo United States Netherlands 15,000\*\* 15,589 46,551 Dow Inc. United States United States 14,025 35,421 34,600 LyondellBasell Industries United States Netherlands 12,53 …
    Axalta Coating Systems Ltd.DSM-Firmenich AG/ADR·425 - Business combination communication·Q2 26·15 May

Key Stats

Trading

Px/Chg 1D$97.38 / +1.27%
Prev Close$95.30
% of 52Wk H98.97%
Avg Volume1.02M
Beta0.22
Mkt Cap24.04B
FD Mkt Cap23.64B

Float

Shrs Out/Float246.87M / 217.04M
Short Float0.00%
Days to Cover0.00
Stock Repurchased$1.18B

Current Valuation

EV27.71B
EV/EBITDA12.52
EV/Sales2.13
P/B1.32
P/S1.85
FCF Yield3.11%
ROE-5.93%
ROA-3.68%
Current Ratio1.59

Dividend

Cash$2.50
Yield3.86%
Yield (TTM)3.86%

Estimates

P/E33.48
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMar '24Mar '25Oct '26
PRICE-BASED RATIOS
Price / Earnings31.4811.5097.90-14.98
Price / Sales4.562.311.919.44
Price / Book Value1.161.071.091.31
Price / Free Cash Flow30.2034.6224.1431.86
ENTERPRISE VALUE METRICS
Enterprise Value27,327.227,115.327,364.527,501.9
Enterprise Value / Sales5.202.552.1410.90
Enterprise Value / EBITDA47.6332.9948.7861.12
Enterprise Value / EBIT57.93-55.9148.78180.93

Financials

Full Financials
Millions EUR5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue-5.7%11,444.08,390.010,627.012,799.09,034.0
Gross Income-4.2%4,187.02,781.02,611.04,245.03,530.0
EBITDA27.6%1,454.01,313.0822.0561.03,851.0
EBIT-4.6%859.0661.0-485.0561.0711.0
Net Income—872.0460.02,137.0250.0-1,081.0
EPS (Diluted)—5.042.61-2.820.94-4.17
BALANCE SHEET
Cash & ST Inv-1.8%2,050.02,880.02,563.02,717.01,903.0
Total Assets16.3%16,020.017,403.034,270.033,747.029,345.0
Total Liabilities13.3%6,623.06,558.011,200.011,050.010,922.0
Total Shareholder Equity18.3%9,318.010,743.022,908.022,511.018,244.0
CASH FLOW
Net Operating Cash Flow-69%1,427.0923.01,265.01,778.01,388.0
Cap Ex15.3%-433.0-644.0-555.0-764.0-764.0
Free Cash Flow-11%994.0279.0710.01,014.0624.0

Enterprise Value Bridge

Millions EUR23 Oct '26
Price (As of 23 Oct '26)109.05
Basic Shares246.87
Market Cap26,921.2
Diluted Shares259.30
Fully Diluted Shares Outstanding259.30
Fully Diluted Market Cap28,276.7
+Consolidated Debt5,663.0
−In-the-Money Convertible Debt—
+Capital Leases463.0
+Operating Leases—
−Cash & Equivalents-1,782.0
−Short-term Investments-121.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest179.0
+Pension Liabilities—
Enterprise Value30,981.2

Related companies

Iqvia Holdings Inc.

IQV US

Wanhua Chemical Group Co., Ltd.

600309 CG

Novozymes As/fi

NVZMY US

L Air Liquide Sa /FI

AIQUY US

EMS-Chemie Holding AG/ADR

EMSHF US

Incyte Corp

INCY US

Grace Fabric Technology Co.,Ltd.

603256 CG

Medpace Holdings, Inc.

MEDP US

Nippon Paint Holdings Co., Ltd.

NPCPF US

Covestro AG/ADR

COVTY US

Symrise AG

SYIEY US

Charles River Laboratories International, Inc.

CRL US